/The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
Article
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
Jialin MengWanhai XuMolecular BiologyJune 1, 2020
Nature Communications
DOI:10.1038/s41467-020-15396-5Keywords:Cabazitaxelcc-byReviews
Join the dialogue
Submit a peer review to improve the scientific record